Jeffrey Z Mann insider trades: Embecta (EMBC) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | EMBC | ↑ Buy | 20,000 | $4.99 | $100K | Direct | Aug 13, 2026 (1d) |
| Aug 10, 2023 | EMBC | ↑ Buy | 4,700 | $21.67 | $102K | Direct | Aug 10, 2023 (0d) |
| Jan 23, 2020 | CMD | ↑ Buy | 750 | $67.30 | $50K | Direct | Jan 23, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EMBC insiders
Open-market trades in the last 12 months
About Jeffrey Z Mann's insider trades
Jeffrey Z Mann is Pres, Pharm Svc&Prod Mgmt, CLO at Embecta (EMBC). Since Jan 23, 2020, Jeffrey has reported 3 open-market purchases worth $252K and no sales on SEC Form 4. In the last 12 months: 1 buy ($100K).
Their filings also include shares withheld for taxes (9 filings), grants and awards (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EMBC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.